The role of nitric oxide in the uterotrophic action of oestradiol after 6 h or 72 h was studied in immature (19\p=n-\21 days old) female Wistar rats by use of l-arginine, the amino acid from which nitric oxide is synthesized, and N\g=w\-nitro-l-argininemethyl ester (l-NAME), an inhibitor of nitric oxide synthase. Oestradiol at single s.c. doses of 2.5, 5.0 and 10.0 \g=m\gper rat induced dose-dependent uterine oedema in 6 h. l-NAME (10 and 20 mg kg\m=-\1, i.p.) administered 30 min before oestradiol (10 \g=m\gper rat) injection suppressed the formation of uterine oedema in a dose-related manner. This action of l-NAME on oestradiol-induced uterine oedema was effectively blocked by pretreatment of rats with l-arginine (600 mg kg \m=-\1 , s.c.), a precursor of nitric oxide, but not by l-lysine, an amino acid not involved in the generation of nitric oxide. In addition, l-NAME at similar doses significantly prevented oestradiol-induced (3 \g=m\gper rat, s.c. on three successive days) increases in uterine growth after 72 h; however, this effect was mitigated by l-arginine (600 mg kg \m=-\1). These results suggest the involvement of an l-arginine\p=n-\nitric oxide system in the oestradiol-induced uterotrophic effect in immature rats.
Introduction
Oestrogen induces a sustained increase in uterine blood flow, stromal oedema and epithelial proliferation (Makowski, 1977;  Phaily and Senior, 1978;  Magness and Rosenfeld, 1989) .
These effects arise from the interactions of oestrogen with a specific receptor protein in the uterine artery and in endome¬ trial stromal cells (Tamaya et al, 1979; Cunha et al, 1983) .
However, the precise mechanism by which oestrogen brings about these changes in the uterus is not completely under¬ stood. Stromal oedema is probably dependent on a synergism between mediators that increase vascular permeability and mediators that enhance blood flow, whereas cellular hypertrophy is probably dependent on the synthesis and regulation of polypeptide growth factors. In this regard, numerous vasoactive substances, like adenosine, acetylcholine, bradykinin, histamine and prostaglandins (Resnick el al, 1976; Still and Greiss, 1978; Clark et al, 1981) , and peptide growth factors, such as transforming growth factor-ct/ epidermal growth factor (TGF-a/EGF) and insulin-like growth factor I (IGF-I) (Murphy et al, 1987; Gardner et al, 1989; Nelson et al, 1992) , have been implicated as the potential mediators because of their vasodilator or growth-promoting actions, but to date no specific antagonist has been able to inhibit or antagonize totally the uterotrophic action of oestrogen.
Yallampalli et al (1994) hypothesized that an L-argininenitric oxide (NO)-cyclic guanosine monophosphate (cGMP) system is present in the uterus and modulates uterine con¬ tractility and Van Buren el al (1992) suggested that oestrogen could induce the available arginine to produce NO. Nitric oxide apparently stimulates soluble guanylate cyclase, increases the cellular concentration of cGMP and relaxes vascular smooth muscle (Ignarro et al, 1986) . In addition, it appears to contribute to maintenance of basal vascular tone and to attenuate the actions of vasoconstrictors in fetal-placental circulation and regulate blood pressure during pregnancy (Myatt et al, 1992) . Chronic inhibition of NO synthesis in pregnant rats can produce a pre-eclampsia-like syndrome in which there is sustained hypertension and intrauterine growth retardation (Molnar et al, 1994 (Moneada et al, 1991; Jovanovic et al, 1994) . Therefore, it is plausible that the uterotrophic effect of oestrogen involves NO.
Most of the biological assays for oestrogen are based upon the increased wet mass in immature or spayed rats (Calhoun el al, 1971) . In the present study, we used this bioassay to investigate the possible involvement of NO in the uterotrophic action of oestradiol, using L-nitroarginine methyl ester (l-NAME) as an inhibitor of NO synthase (Rees et al, 1990 ) and immature rats as a model system (Ramalay, (Psychoyos, 1966; Phaily and Senior, 1978; Marshall and Senior, 1986 
